Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

High dose consensus interferon in nonresponders to interferon alpha-2b and ribavirin with chronic hepatitis C.

Moskovitz DN, Manoharan P, Heathcote EJ.

Can J Gastroenterol. 2003 Aug;17(8):479-82.

PMID:
12945008
2.

Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.

Keeffe EB, Hollinger FB.

Hepatology. 1997 Sep;26(3 Suppl 1):101S-107S. Review.

PMID:
9305673
3.

Comparative efficacy and overall safety of different doses of consensus interferon for treatment of chronic HCV infection: a systematic review and meta-analysis.

Alavian SM, Behnava B, Tabatabaei SV.

Eur J Clin Pharmacol. 2010 Nov;66(11):1071-9. doi: 10.1007/s00228-010-0881-7. Epub 2010 Sep 21. Review.

PMID:
20857094
4.

Approach to the management of patients with chronic hepatitis C who failed to achieve sustained virologic response.

Sethi A, Shiffman ML.

Clin Liver Dis. 2005 Aug;9(3):453-71, vii-viii. Review.

PMID:
16023977
5.
6.
7.

Treatment of chronic hepatitis C with consensus interferon in relapsers and non-responders to interferon-based therapy.

Steffen M, Cornberg M, Buggisch P.

Hepatogastroenterology. 2007 Dec;54(80):2368-72. Review.

PMID:
18265667
8.

Treatment of chronic hepatitis C in nonresponders to interferon monotherapy.

Kwo PY.

Curr Gastroenterol Rep. 2000 Feb;2(1):11-7. Review.

PMID:
10980998
9.
10.

[The European consensus on hepatitis C].

Kolarski V.

Vutr Boles. 1999;31(4):21-8. Review. Bulgarian.

PMID:
10989671
11.

[Case of ANCA associated vasculitis induced by interferon therapy for HCV infection].

Watanabe T, Oono Y, Takeshita E, Kobayashi Y, Tanaka Y, Joko K, Ooshiro Y.

Nihon Shokakibyo Gakkai Zasshi. 2008 Dec;105(12):1787-93. Review. Japanese.

PMID:
19057165

Supplemental Content

Support Center